Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Published:2015-12 Issue:50 Volume:94 Page:e2239
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Chen Yu-Mu,Lai Chien-Hao,Chang Huang-Chih,Chao Tung-Ying,Tseng Chia-Cheng,Fang Wen-Feng,Wang Chin-Chou,Chung Yu-Hsiu,Huang Kuo-Tung,Chen Hung-Cheng,Chang Ya-Chun,Lin Meng-Chih

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference34 articles.

1. Lung cancer incidence trends among men and women - United States, 2005-2009.;Henley;MMWR Morb Mortal Wkly Rep,2014

2. Lung cancer and prognosis in Taiwan: a population-based cancer registry.;Wang;J Thorac Oncol,2013

3. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.;Tokumo;Clin Cancer Res,2005

4. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.;Kosaka;Cancer Res,2004

5. Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment.;Jida;Cancer Sci,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28

2. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer;Medicine;2023-09-22

3. Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies;Tumor Biology;2023-05-23

4. Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;JCO Precision Oncology;2021-10

5. The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer;PLOS ONE;2017-06-07